BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Aduro Biotech 

626 Bancroft Way
Suite 3C
Berkeley  California  94710  U.S.A.
Phone: 510-848-4400 Fax: n/a


SEARCH JOBS




Industry
Biotechnology

Segment
Biotechnology





 Company News
Aduro Biotech Announces Interim Phase 1B Clinical Data Of CRS-207 For The Treatment Of Mesothelioma Accepted For Oral Presentation At The International Mesothelioma Interest Group Conference 10/16/2014 11:23:28 AM
Berkeley's Aduro Biotech Strikes $817 Million Lung Cancer Pact With Janssen Biotech Inc. (JNJ) 10/16/2014 6:50:36 AM
Aduro Biotech’s Chief Scientific Officer, Thomas W. Dubensky, Jr., Ph.D., Featured Speaker On Action Of Vaccine Adjuvants At Keystone Symposia 10/9/2014 10:49:25 AM
Aduro Biotech Receives Breakthrough Therapy Designation From FDA For Innovative Pancreatic Cancer Combination Immunotherapy 7/21/2014 6:37:52 AM
Aduro Biotech Names Industry Veteran And Academic Leader, Gerald Chan, DSc To Its Board Of Directors 7/17/2014 8:05:29 AM
With Johnson & Johnson (JNJ) Deals, Berkeley's Aduro Biotech Gets New Chance To Prove Worth 6/18/2014 7:59:43 AM
Berkeley's Aduro Biotech Reels In $55 Million Series C Financing 6/11/2014 3:04:04 PM
Aduro Biotech Announces American Society of Clinical Oncology Presentation Of Promising Results From Phase 1b Clinical Trial Of Its Novel Immunotherapy For The Treatment Of Mesothelioma 6/2/2014 10:46:52 AM
Johnson & Johnson (JNJ)'s Janssen Biotech Inc. (JNJ) Licenses LADD From Bay Area's Aduro Biotech In Deal Worth $365 Million 5/29/2014 7:36:19 AM
Aduro Biotech Announces Pancreatic Cancer And Mesothelioma Abstracts To Be Presented At 2014 American Society of Clinical Oncology Annual Meeting 5/21/2014 6:34:05 AM
12345